Skip to main content
SpringerLink
Log in

Information for Patients and Safety Considerations

  • Chapter
  • First Online:
Mohs Micrographic Surgery

  • 1870 Accesses

Abstract

The proper execution of Mohs surgery requires proper planning. Both patient and physician alike must be adequately prepared for the procedure in order to optimize outcomes and enhance safety. For the Mohs surgeon, this entails maximizing the preoperative visit, where the patient can be properly assessed for any conditions or comorbidities that may pose a real or potential risk to the patient during or after the procedure. The Mohs surgeon should be well versed on safety issues commonly encountered in skin cancer patients, such as cardiovascular complications, antibiotic prophylaxis for infections, anticoagulation issues, and anesthesia safety. Patients should also be educated about the procedure as well as their role in postoperative care. Staff must also be informed about office safety protocols and should be trained on how to respond to potential office emergencies.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Cook JL, Perone JB. A prospective evaluation of the incidence of complications associated with Mohs micrographic surgery. Arch Dermatol. 2003;139:143–52.

    Article  PubMed  Google Scholar 

  2. Kouba DJ, Moy RL. Complications and pitfalls of skin cancer surgery/Mohs micrographic surgery. In: Nouri K, editor. Complications in dermatologic surgery. Philadelphia: Mosby Elsevier; 2008. p. 37–63.

    Google Scholar 

  3. Otley CC. Continuation of medically necessary aspirin and warfarin during cutaneous surgery. Mayo Clin Proc. 2003;78:1392–6.

    Article  PubMed  Google Scholar 

  4. Matzke TJ, Christenson LJ, Christenson SD, Atanashova N, Otley CC. Pacemakers and implantable cardiac defibrillators in dermatologic surgery. Dermatol Surg. 2006;32:1155–62.

    Article  PubMed  CAS  Google Scholar 

  5. Aggarwal A, Farber NE, Kotter GS, Dhamee MS. Electrosurgery-induced ventricular fibrillation during pacemaker replacement: a unique mechanism. J Clin Monit. 1996;12:339–42.

    Article  PubMed  CAS  Google Scholar 

  6. Kellow NH. Pacemaker failure during transurethral resection of the prostate. Anaesthesia. 1993;48:136–8.

    Article  PubMed  CAS  Google Scholar 

  7. Krull EA, Pickard SD, Hall JC. Effects of electrosurgery on cardiac pacemakers. J Dermatol Surg. 1975;1:43–5.

    PubMed  CAS  Google Scholar 

  8. El-Gamal HM, Dufresne RG, Saddler K. Electrosurgery, pacemaker and ICDs: a survey of precautions and complications experienced by cutaneous surgeons. Dermatol Surg. 2001;27:385–90.

    Article  PubMed  CAS  Google Scholar 

  9. Hayes DL, Vliestra RE. Pacemaker malfunction. Ann Intern Med. 1993;119:828–35.

    PubMed  CAS  Google Scholar 

  10. Fader DJ, Johnson TM. Medical issues and emergencies in the dermatology office. J Am Acad Dermatol. 1997;36:1–16.

    Article  PubMed  CAS  Google Scholar 

  11. Epsein MR, Mayer Jr JE, Duncan BW. Use of an ultrasonic scalpel as an alternative to electrocautery in patients with pacemakers. Ann Thorac Surg. 1998;65:1802–4.

    Article  Google Scholar 

  12. Stenquist BC, Holt PJ, Motley RJ. Computerized bipolar diathermy with scissors and forceps in cutaneous surgery. Dermatol Surg. 2002;28:601–2.

    Article  PubMed  Google Scholar 

  13. Rhinehart BM, Murphy ME, Farley MF, Albertini JG. Sterile versus nonsterile gloves during Mohs micrographic surgery: infection rate is not affected. Dermatol Surg. 2006;32:170–6.

    Article  PubMed  CAS  Google Scholar 

  14. Whitaker DC, Grande DJ, Johnson SS. Wound infection rates in dermatologic surgery. J Dermatol Surg Oncol. 1988;14:525–8.

    PubMed  CAS  Google Scholar 

  15. Maragh S, Brown M. Prospective evaluation of surgical site infection rate among patients with Mohs micrographic surgery without the use of prophylactic antibiotics. J Am Acad Dermatol. 2008;59:275–8.

    Article  PubMed  Google Scholar 

  16. Dineen P. Prevention and treatment of deep wound infections. In: The surgical wound. Media: Lea & Febiger; 1981. p. 146–9.

    Google Scholar 

  17. Wright TI, Baddour LM, Berbari EF, et al. Antibiotic prophylaxis in dermatologic surgery: advisory statement 2008. J Am Acad Dermatol. 2008;59:464–73.

    Article  PubMed  Google Scholar 

  18. Kovich O, Otley CC. Thrombotic complications related to discontinuation of warfarin and aspirin therapy perioperatively for cutaneous operation. J Am Acad Dermatol. 2003;48:233–7.

    Article  PubMed  Google Scholar 

  19. Goldsmith SM, Leshin B, Owen J. Management of patients taking anticoagulants and platelet inhibitors prior to dermatologic surgery. J Dermatol Surg Oncol. 1993;19:578–81.

    PubMed  CAS  Google Scholar 

  20. Otley CC, Fewkes JL, Frank W, Olbrich SM. Complications of cutaneous surgery in patients who are taking warfarin, aspirin, or nonsteroidal anti-inflammatory drugs. Arch Dermatol. 1996;132:161–6.

    Article  PubMed  CAS  Google Scholar 

  21. Billingsley EM, Maloney ME. Intraoperative and postoperative bleeding problems in patients taking warfarin, aspirin, and nonsteroidal anti-inflammatory agents: a prospective study. Dermatol Surg. 1997;23:381–3.

    Article  PubMed  CAS  Google Scholar 

  22. Bartlett GR. Does aspirin affect the outcome of minor cutaneous surgery? Br J Plast Surg. 1999;52:214–6.

    Article  PubMed  CAS  Google Scholar 

  23. Lawrence C, Sakuntabhai A, Tiling-Grosse S. Effect of aspirin and nonsteroidal anti-inflammatory drug therapy on bleeding complications in dermatologic surgical patients. J Am Acad Dermatol. 1994;31:988–92.

    Article  PubMed  CAS  Google Scholar 

  24. Alcalay J. Cutaneous surgery in patients receiving warfarin therapy. Dermatol Surg. 2001;27:756–8.

    Article  PubMed  CAS  Google Scholar 

  25. Ostad A, Kageyama N, Moy RL. Tumescent anesthesia with a lidocaine dose of 55 mg/kg is safe for liposuction. Dermatol Surg. 1996;22:921–7.

    Article  PubMed  CAS  Google Scholar 

  26. Venkat AP, Coldiron B, Balkrishnan R, Camacho F, Hancox JG, Fleischer Jr AB, et al. Lower adverse event and mortality rates in physician offices compared with ambulatory surgery centers: a reappraisal of Florida adverse event data. Dermatol Surg. 2004;30(12 pt 1):1444–51.

    Article  PubMed  Google Scholar 

  27. Elston DM, Taylor JS, Coldiron B, Hood AF, Read SI, Resneck JS, et al. Patient safety. Part I. Patient safety and the dermatologist. J Am Acad Dermatol. 2009;61(2):179–90.

    Article  PubMed  Google Scholar 

  28. Becker DE, Reed KL. Essentials of local anesthetic pharmacology. Anesth Prog. 2006;53:98–109.

    Article  PubMed  Google Scholar 

  29. Foldes FF, Molloy R, McNall PG, Koukal LR. Comparison of toxicity of intravenously given local anesthesia agents in man. JAMA. 1960;172:1493–8.

    Article  CAS  Google Scholar 

  30. Alam M, Ricci D, Havey J, Rademaker A, Witherspoon J, West DP. Safety of peak serum lidocaine concentration after Mohs micrographic surgery: a prospective cohort study. J Am Acad Dermatol. 2010;63:87–92.

    Article  PubMed  CAS  Google Scholar 

  31. Butterwick KJ, Goldman MP, Sriprachya-Anunt S. Lidocaine levels during the first two hours of infiltration of dilute anesthetic solution for tumescent liposuction: rapid versus slow delivery. Dermatol Surg. 1999;25:681–90.

    Article  PubMed  CAS  Google Scholar 

  32. Tolle MA, Schwarzwald HL. Postexposure prophylaxis against human immunodeficiency virus. Am Fam Physician. 2010;82(2):161–6.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Loma Linda University School of Medicine, Loma Linda, CA, USA

    Ilya Reyter, Abel Torres & Neda Mehr

Authors
  1. Ilya Reyter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abel Torres
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Neda Mehr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Abel Torres .

Editor information

Editors and Affiliations

  1. Miller School of Medicine, Dept. Dermatology, University of Miami, NW. 10th Ave. 1600, Miami, 33136, Florida, USA

    Keyvan Nouri

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag London Limited

About this chapter

Cite this chapter

Reyter, I., Torres, A., Mehr, N. (2012). Information for Patients and Safety Considerations. In: Nouri, K. (eds) Mohs Micrographic Surgery. Springer, London. https://doi.org/10.1007/978-1-4471-2152-7_44

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2152-7_44

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2151-0

  • Online ISBN: 978-1-4471-2152-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation